COMPLEMENTARY Medicines Association (CMA) ceo Carl Gibson has quipped that he "won't sleep until melatonin is rescheduled".
He said CMA is disappointed that melatonin won't be made available to Australian consumers without a prescription as it is in other areas around the globe including the US and Canada.
This follows a decision by the Advisory Committee on Medicines Scheduling that melatonin for human use will for now remain in Schedule 4 of the Poisons Standard.
Gibson said a chief concern was the amount of unregulated melatonin being purchased online from dubious overseas sources.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Feb 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Feb 17